OPHTHALMIC GENE THERAPY

Do you have aN OPHTHALMIC GENE THERAPY for Glaucoma or AMD?

317-hd-loop-min.gif
 

Gene therapies are emerging as a new force for hope across the medical spectrum and perhaps offer the most immediately impactful solution to multiple ophthalmic diseases.

Today, gene therapies are administered to target tissues in a random manor, however DARC offers the opportunity to identify active or non-active disease sites within the retina. This ability will enable you to correctly administer gene therapies to the target tissue.

 
 

HOW CAN DARC HELP YOU?

 
GENE-2--_-TEST.png

ASSISTING TARGETED DELIVERY

DARC can be used in gene therapy by pin-pointing anatomical disease activity, your gene therapy can then be targeted to the appropriate area.

 
 

De-risk your gene & cell therapies with DARC.